The Approval Process in Action
|
Source: The Life Sciences Report and Visual Capitalist (5/1/13)
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.
Related Articles
Biotech Shares Positive Phase I Data for Alzheimer's Treatment
Source: Dr. Douglas Loe (10/31/2024)
Leede Financial Inc.'s target price on ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM) reflects a potential return of 822%.
AI Healthcare Co. With 'Bright' Outlook Closes Placement
Source: Streetwise Reports (10/31/2024)
Healthcare artificial intelligence (AI) company Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has closed a non-brokered private placement for aggregate gross proceeds of CA$1.95 million. Find out why one analyst says the stock is a Strong Buy and worth going overweight on.
Mass. Biotech Shares Strong Q3 Results
Source: Dr. David Nierengarten (10/29/2024)
Kiniksa Pharmaceuticals Ltd. (KNSA:NASDAQ) recently reported strong Q3 2024 earnings, which led to its Outperform rating, according to a Wedbush research note.
Boston Biotech Announces Novartis Collaboration
Source: Dr. Robert Driscoll (10/28/2024)
Monte Rose Therapeutics Inc. (GLUE:NASDAQ) recently unveiled a collaborative agreement with Novartis for the development of MRT-6160, its VAV1-degrader program, according to a Wedbush research note.
Regenerative Medicine Co. May Have Solution to Delivering Cell Treatments
Source: Streetwise Reports (10/28/2024)
This Canadian life sciences firm is developing an implantable cell-containing pouch, shown in clinical trial data thus far to be safe, well-tolerated and effective. Learn why several analysts rate the company Buy.
Recommended Articles
Biotech Shares Positive Phase I Data for Alzheimer's Treatment
Source: Dr. Douglas Loe (10/31/2024)
AI Healthcare Co. With 'Bright' Outlook Closes Placement
Source: Streetwise Reports (10/31/2024)
Mass. Biotech Shares Strong Q3 Results
Source: Dr. David Nierengarten (10/29/2024)
Boston Biotech Announces Novartis Collaboration
Source: Dr. Robert Driscoll (10/28/2024)
Regenerative Medicine Co. May Have Solution to Delivering Cell Treatments
Source: Streetwise Reports (10/28/2024)
